the market leader in automated hand hygiene and infection prevention technology, announced that it has recorded more than 1 billion hand hygiene opportunities (HHOs) since the company’s founding in 2012. This milestone reflects the ongoing...
Bruker Corporation announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker’s post-genomic solutions...
during their second RSV season. Both the U.S. and EU applications are supported by data from the Phase 3 SMART trial (MK-1654-007), which were presented at RSVVW’26, the 9th conference of the Respiratory Syncytial Virus Foundation (ReSViNET), in...
(FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can...
Grows as Drug Spending Rises National prescription drug spending increased 7.9% to $467 billion in 2024 after growing 10.8% the previous year, according to the Centers for Medicare & Medicaid Services (CMS). Retail prescription drug spending is...
a clinical-grade supplement company specializing in evidence-based formulation, announced the launch of BioActive Vitamin B1™ Clinical Strength, a complete B1 activation system delivering 600mg benfotiamine at the research-matched dose alongside a...
more than digestion alone. resB specifically targets the Gut-Lung Axis, using resbiotic's proprietary probiotic strains (RSB11®, RSB12®, and RSB13®) to support respiratory health from the inside out. Few places understand the need for daily...
to present eligible investors with the opportunity to participate in a $20 million financing for Thplasma comprising a $15 million equity investment and a $5 million venture debt facility. Thplasma is a U.S.-based pharmaceutical company operating...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch1 of Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials. Glenmark's Sugammadex Injection is bioequivalent and therapeutically equivalent to...
healthcare challenges associated with chronic diseases, including obesity and type 2 diabetes. Global demand for GLP‑1 therapies has highlighted the critical need for delivery systems that enable safe, accurate, and consistent dosing for patients....
the life sciences and healthcare industries, announced the closing of $25 million in growth capital. The round includes a $17 million senior credit facility from BOK Financial and $8 million in equity from existing investors and a group of global...
of Tracy Gibbs, PhD, as Chief Executive Officer. The leadership transition marks a significant milestone for the 14-month-old company as it accelerates the global expansion of its needle-free peptide delivery technology. Gibbs, PhD, is a nationally...
Roche announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its cobas® BV/CV (Bacterial vaginosis/Candida vaginitis) assay. This molecular diagnostic test provides results for both Bacterial vaginosis (BV) and...
Haisco Pharmaceutical Group claimed today their independently developed Class 1 innovative drug, Ciprocopan Succinate Tablets (development code: HSK39297), has received marketing approval from the National Medical Products Administration of China...
and lead. Don’t miss the professional development event everyone will be talking about—join us in Grapevine, Texas, July 18-21, for bold ideas, powerful connections, and real-world impact. Pharmacy Education 2026 is your chance to grow, learn, and...
for fiscal year 2026, updates shareholders on the Company's strategic focus, and reflects the Company's recently completed 1-for-25 share consolidation. The full Annual Report is available on the U.S. Securities and Exchange Commission's website...
to treat opioid use disorder, and legislation requiring naloxone co-prescription or education has been enacted in 18 states. However, guidance for prescribing naloxone to pediatric patients had been historically left out of this discussion. CHOP,...
cancer is the fourth most common cancer in women but is largely preventable through HPV vaccination and regular screening.1 Evidence shows that organized screening and early detection reduces deaths from cervical cancer, with mortality reduction...
objective response rate (ORR) and PFS, as well as a significant overall survival benefit — reducing the risk of death by 51% versus chemotherapy with or without bevacizumab. ”The approval of Erbitux in combination with encorafenib and FOLFOX marks...
follow-up." The sNDA submission was supported by substantial long-term safety and efficacy data from three ongoing studies (111-205, 111-208 and 111-302), including clinically meaningful results in growth and improvements across key skeletal...
